Out of Academia

In a blog post at DeviceRandom, Massimo Sandal says why he left not only his chemistry postdoc at the University of Cambridge, but also why he chose to leave academia altogether. While he wasn't overly optimistic about his most recent research project, Sandal says he chose to leave the lab because he thinks there are problems within the "practice of science itself." While he says he still loves science, he's not so enamored with the high-stakes "competition for funding and positions" he's seen within it.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.